Sign in

CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company

Serina Therapeutics, Inc.

Sign in to watch
Ticker
SER
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
AL
Entity type
operating
EIN
821436829
Phone
(256) 327-9630
Business address
601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
Former names
AgeX Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale Chief Scientific Officer sold 6,500 shares at $3.03 ($19,680)
  6. 4 Planned sale Chief Scientific Officer sold 6,500 shares at $3.57 ($23,186)
  7. 4 Planned sale Chief Scientific Officer sold 2,500 shares at $2.95 ($7,375)
  8. 4 Planned sale Chief Scientific Officer sold 4,000 shares at an average $3.04 ($12,140)
  9. 4 Planned sale Chief Scientific Officer sold 6,500 shares at an average $2.50 ($16,253)
  10. 4 Planned sale Chief Scientific Officer sold 13,000 shares at $2.69 ($34,953)
  11. 4 Planned sale Chief Scientific Officer sold 4,100 shares at $2.60 ($10,660)
  12. 4 Planned sale Chief Scientific Officer sold 5,673 shares at $2.67 ($15,168)
  13. 4 Planned sale Chief Scientific Officer sold 3,227 shares at $2.96 ($9,562)
  14. 4 Planned sale Chief Scientific Officer sold 1,700 shares at $3.26 ($5,541)
  15. 4 Planned sale Chief Scientific Officer sold 3,555 shares at $3.24 ($11,520)
  16. 4 Planned sale Chief Scientific Officer sold 1,245 shares at an average $3.33 ($4,149)
  17. 4 Planned sale Chief Scientific Officer sold 6,500 shares at an average $3.61 ($23,481)
  18. 4 Planned sale Chief Scientific Officer sold 5,965 shares at $3.90 ($23,264)
  19. 4 Planned sale Chief Scientific Officer sold 535 shares at $3.94 ($2,105)
  20. 4 Planned sale Chief Scientific Officer sold 6,500 shares at $3.75 ($24,402)

Page 2 of 9 · 177 filings